Eversheds Sutherland advises MicroAire Surgical Instruments on the acquisition of Neosyad
February 05, 2025
Eversheds Sutherland advises MicroAire Surgical Instruments on the acquisition of NeosyadFebruary 05, 2025 Our team in France has advised MicroAire Surgical Instruments LLC on its acquisition of Neosyad, an innovative French medical device company which specialises in adipose tissue engineering. MicroAire Surgical Instruments LLC is a global leader in surgical power tools and medical devices, headquartered in Charlottesville, Virginia. Neosyad is an innovative French medical device company in adipose tissue engineering for reconstructive and plastic surgery applications. The sale was completed by Neosyad’s co-founders and minority shareholders. This strategic transaction enhances MicroAire’s capabilities in the field of medical device innovation, strengthening its market presence and expanding its expertise in adipose tissue engineering technology. In Paris, the Eversheds Sutherland team was led by Franck Bourgeois (partner), Doriane Shannon (senior associate) and Benjamin Grunebaum (associate) for the corporate/M&A aspects of the transaction. The due diligences of the transaction involved Gaëtan Cordier (partner) and Brian Robion (associate) for intellectual property as well as Deborah Attali (partner), Anne Cognet (counsel) and Nicolas Etcheparre (counsel) in employment law. The sellers were assisted by Akléa in Corporate, M&A and IT law. Investment bank: Hottinguer. Latest Insights
Latest News
Latest Events
legal updates October 08, 2026 SEC proposes to modernize performance fee rules and expand accredited inves... legal updates October 08, 2026 CFTC issues staff advisory on “mention market” event contracts legal updates October 07, 2026 EU: Proposed KIDS Act Targets Online Child Safety guides and reports October 07, 2026 Technology, AI and the changing legal landscape of M&A firm news October 07, 2026 Faster deals, deeper diligence: AI is transforming the legal landscape of M... client news October 06, 2026 Eversheds Sutherland Advises Infranity on Closing of $300 Million Holding C... client news October 06, 2026 Eversheds Sutherland Advises Ives Ultra AI Opportunities Inc. on $200 Milli... firm news October 05, 2026 Leading finance partner joins Eversheds Sutherland |